Hexamethonium bromide

This classification denotes a nicotinic antagonist with the molecular formula C12H30N2.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8J77X3S603, chemically known as 1,6-hexanediaminium, n,n,n,n,n,n-hexamethyl-, dichloride but more generally known as hexamethonium bromide, which bears US NIH Compound Identifier 3604. European Medicines Agency schedules Hexamethonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08028MIG. The term HEXAMETHONIUM BROMIDE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule hexamethonium bromide under HS 29239000 and SITC 51481. As of Q4 2014, HEXAMETHONIUM BROMIDE remains US FDA's Preferred Term for this commodity. Hexamethonium bromide bears US NLM identifiers UMLS ID C0121631 and NCI Concept Code C80001. SMILES: C[N+](C)(C)CCCCCC[N+](C)(C)C.[BR-].[BR-].